These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8610630)

  • 1. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
    Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
    Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.
    Porter AT
    Eur Urol; 1994; 26 Suppl 1():20-5. PubMed ID: 7537665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
    Kasalický J; Krajská V
    Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone.
    McEwan AJ; Amyotte GA; McGowan DG; MacGillivray JA; Porter AT
    Eur Urol; 1994; 26 Suppl 1():26-31. PubMed ID: 7537666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
    Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
    Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
    Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
    Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy.
    Laing AH; Ackery DM; Bayly RJ; Buchanan RB; Lewington VJ; McEwan AJ; Macleod PM; Zivanovic MA
    Br J Radiol; 1991 Sep; 64(765):816-22. PubMed ID: 1717094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
    Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of current clinical experience with strontium-89 (Metastron).
    Bos SD
    Prostate Suppl; 1994; 5():23-6. PubMed ID: 8172712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT; McEwan AJ
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone.
    Lewington VJ; McEwan AJ; Ackery DM; Bayly RJ; Keeling DH; Macleod PM; Porter AT; Zivanovic MA
    Eur J Cancer; 1991; 27(8):954-8. PubMed ID: 1716935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.